Login / Signup

Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction.

Francesco GiallauriaGiuseppe VitaleMario PacileoAnna Di LorenzoAlessandro OlivieroFrancesco PassaroRoberta CalceAlessandro ParlatoCrescenzo TestaGiuseppe D'AmbrosioGiuseppe RomanoFrancesco ClemenzaSilvia SarulloElio VenturiniMarco GentileCinzia NugaraGabriella IannuzzoAntonello D'AndreaCarlo VigoritoFilippo Maria Sarullo
Published in: Journal of clinical medicine (2020)
In HFrEF patients, S/V therapy improves autonomic function, functional capacity, and ventilation. Whether these findings might translate into beneficial effects on prognosis and outcome remains to be elucidated.
Keyphrases
  • ejection fraction
  • end stage renal disease
  • heart rate variability
  • heart rate
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • stem cells
  • mesenchymal stem cells